M. Petri, A. Orbai, G. Alarcón, C. Gordon, J. Merrill et al., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis & Rheumatism, vol.65, issue.Suppl, pp.2677-86, 2012.
DOI : 10.1111/j.1523-1755.2004.00443.x

F. Arnett, S. Edworthy, D. Bloch, D. Mcshane, J. Fries et al., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-339, 1988.
DOI : 10.1002/art.1780310302

D. Aletaha, T. Neogi, A. Silman, J. Funovits, D. Felson et al., 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1580-1588, 2010.
DOI : 10.1136/ard.2010.138461

URL : https://hal.archives-ouvertes.fr/hal-01557559

L. Iaccarino, M. Gatto, S. Bettio, F. Caso, M. Rampudda et al., Overlap connective tissue disease syndromes, Autoimmunity Reviews, vol.12, issue.3, pp.363-73, 2013.
DOI : 10.1016/j.autrev.2012.06.004

R. Panush, N. Edwards, S. Longley, and E. Webster, 'Rhupus' Syndrome, Archives of Internal Medicine, vol.148, issue.7, pp.1633-1639, 1988.
DOI : 10.1001/archinte.1988.00380070117028

C. Pipili, A. Sfritzeri, and E. Cholongitas, Deforming arthropathy in systemic lupus erythematosus, European Journal of Internal Medicine, vol.19, issue.7, pp.482-489, 2008.
DOI : 10.1016/j.ejim.2008.01.017

A. Fernández, G. Quintana, E. Matteson, J. Restrepo, F. Rondón et al., Lupus arthropathy: historical evolution from deforming arthritis to rhupus, Clinical Rheumatology, vol.21, issue.6, pp.523-529, 2004.
DOI : 10.7326/0003-4819-72-1-49

L. Amezcua-guerra, R. Springall, R. Marquez-velasco, L. Gómez-garcía, A. Vargas et al., Presence of antibodies against cyclic citrullinated peptides in patients with " rhupus " : a cross-sectional study, Arthritis Research & Therapy, vol.8, issue.5, p.144, 2006.
DOI : 10.1186/ar2036

J. Simón, J. Granados, J. Cabiedes, J. Morales, and J. Varela, Clinical and immunogenetic characterization of Mexican patients with ???Rhupus???, Lupus, vol.9, issue.5, pp.287-92, 2002.
DOI : 10.1177/096120330000900110

J. Smolen, D. Aletaha, and I. Mcinnes, Rheumatoid arthritis, The Lancet, vol.388, issue.10055, pp.2023-2061, 2016.
DOI : 10.1016/S0140-6736(16)30173-8

URL : https://hal.archives-ouvertes.fr/hal-01558198

F. Guillemin, A. Saraux, P. Guggenbuhl, C. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France: 2001, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1427-1457, 2001.
DOI : 10.1136/ard.2004.029199

G. Kitas and S. Gabriel, Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives, Annals of the Rheumatic Diseases, vol.70, issue.1, pp.8-14, 2011.
DOI : 10.1136/ard.2010.142133

I. Mcinnes and G. Schett, The Pathogenesis of Rheumatoid Arthritis, New England Journal of Medicine, vol.365, issue.23, pp.2205-2224, 2011.
DOI : 10.1056/NEJMra1004965

G. Firestein and I. Mcinnes, Immunopathogenesis of Rheumatoid Arthritis, Immunity, vol.46, issue.2, pp.183-96, 2017.
DOI : 10.1016/j.immuni.2017.02.006

J. Scher, D. Littman, and S. Abramson, Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases, Arthritis & Rheumatology, vol.132, issue.Suppl 1, pp.35-45, 2016.
DOI : 10.1053/j.gastro.2006.11.022

M. Konig, L. Abusleme, J. Reinholdt, R. Palmer, R. Teles et al., Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis, Science Translational Medicine, vol.41, issue.10, pp.369-176, 2016.
DOI : 10.1128/JCM.41.10.4829-4832.2003

K. Klein and S. Gay, Epigenetics in rheumatoid arthritis, Current Opinion in Rheumatology, vol.27, issue.1, pp.76-82, 2015.
DOI : 10.1097/BOR.0000000000000128

M. Pearson and S. Jones, Review: Long Noncoding RNAs in the Regulation of Inflammatory Pathways in Rheumatoid Arthritis and Osteoarthritis, Arthritis & Rheumatology, vol.16, issue.Suppl 1, pp.2575-2583, 2016.
DOI : 10.1016/j.joca.2007.06.006

W. Van-venrooij and G. Pruijn, How citrullination invaded rheumatoid arthritis research, Arthritis Research & Therapy, vol.16, issue.1, p.103, 2014.
DOI : 10.1111/all.12111

E. Choy, Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis, Rheumatology, vol.51, issue.suppl 5, pp.3-11, 2012.
DOI : 10.1093/rheumatology/kes113

V. Goëb, M. Thomas-l-'otellier, R. Daveau, R. Charlionet, P. Fardellone et al., Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes, Arthritis Research & Therapy, vol.11, issue.2, p.38, 2009.
DOI : 10.1186/ar2644

V. A. Derksen, T. Huizinga, and D. Van-der-woude, The role of autoantibodies in the pathophysiology of rheumatoid arthritis, Seminars in Immunopathology, vol.388, issue.10055, pp.437-483, 2017.
DOI : 10.1016/s0140-6736(16)30173-8

V. Goëb, P. Dieudé, R. Daveau, M. Thomas-l-'otellier, F. Jouen et al., Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis, Rheumatology, vol.47, issue.8, pp.1208-1220, 2008.
DOI : 10.1093/rheumatology/ken192

G. Schellekens, H. Visser, B. De-jong, F. Van-den-hoogen, J. Hazes et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide, Arthritis & Rheumatism, vol.350, issue.1, pp.155-63, 2000.
DOI : 10.1016/S0140-6736(97)01300-7

G. Burmester, A. Pratt, H. Scherer, and J. Van-laar, EULAR Textbook on rheumatic diseases.1 ère édition, JWJ Bijlsma, 2012.

D. Heijde, . Van-der, A. Mil, H. Van-der, D. Aletaha et al., EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria, Annals of the Rheumatic Diseases, vol.72, issue.4, pp.479-81, 2013.
DOI : 10.1136/annrheumdis-2012-202779

URL : https://hal.archives-ouvertes.fr/hal-01558198

L. Arnaud, J. Fagot, A. Mathian, M. Paita, A. Fagot-campagna et al., Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study, Autoimmunity Reviews, vol.13, issue.11, pp.1082-1091, 2014.
DOI : 10.1016/j.autrev.2014.08.034

G. Bertsias, J. Salmon, and D. Boumpas, Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1603-1614, 2010.
DOI : 10.1136/ard.2010.135186

G. Tsokos, Systemic Lupus Erythematosus, New England Journal of Medicine, vol.365, issue.22, pp.2110-2131, 2011.
DOI : 10.1056/NEJMra1100359

A. Kaul, C. Gordon, M. Crow, Z. Touma, M. Urowitz et al., Systemic lupus erythematosus, Nature Reviews Disease Primers, vol.67, p.16039, 2016.
DOI : 10.1002/acr.22452

S. Eyre, G. Orozco, and J. Worthington, The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping, Nature Reviews Rheumatology, vol.2, issue.7, pp.421-453, 2017.
DOI : 10.7554/eLife.00471

R. Cervera, M. Khamashta, J. Font, G. Sebastiani, A. Gil et al., Systemic Lupus Erythematosus, Medicine, vol.72, issue.2, pp.113-137, 1993.
DOI : 10.1097/00005792-199303000-00005

URL : https://hal.archives-ouvertes.fr/hal-01563359

D. Alarcón-segovia, M. Alarcón-riquelme, M. Cardiel, F. Caeiro, L. Massardo et al., Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort, Arthritis & Rheumatism, vol.15, issue.4, pp.1138-1185, 2005.
DOI : 10.1001/archinte.1988.00380070117028

M. Cohen and J. Webb, Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases., Annals of the Rheumatic Diseases, vol.46, issue.11, pp.853-861, 1987.
DOI : 10.1136/ard.46.11.853

C. Brand, M. Rowley, B. Tait, K. Muirden, and S. Whittingham, Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features., Annals of the Rheumatic Diseases, vol.51, issue.2
DOI : 10.1136/ard.51.2.173

URL : http://ard.bmj.com/content/annrheumdis/51/2/173.full.pdf

A. Fernández, G. Quintana, F. Rondón, J. Restrepo, A. Sánchez et al., Lupus arthropathy: a case series of patients with rhupus, Clinical Rheumatology, vol.114, issue.2, pp.164-171, 2006.
DOI : 10.1097/00000441-196011000-00008

M. Chan, P. Owen, J. Dunphy, B. Cox, C. Carmichael et al., Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus, J Rheumatol, vol.35, pp.77-83, 2008.

Y. Zhao, J. Li, X. Li, C. Li, L. Li et al., What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?, Joint Bone Spine, vol.76, issue.5, pp.501-508, 2009.
DOI : 10.1016/j.jbspin.2008.11.007

C. Tani, D. Aniello, D. , D. Sedie, A. Carli et al., Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients, Autoimmunity Reviews, vol.12, issue.4, pp.537-578, 2013.
DOI : 10.1016/j.autrev.2012.09.004

J. Li, H. Wu, X. Huang, D. Xu, W. Zheng et al., Clinical Analysis of 56 Patients with Rhupus Syndrome, Medicine, vol.93, issue.10, 2014.
DOI : 10.1097/MD.0000000000000049

L. Amezcua-guerra, R. Márquez-velasco, and R. Bojalil, Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies, Inflammation Research, vol.57, issue.12, pp.555-562, 2008.
DOI : 10.1007/s00011-008-8110-x

E. Benavente and S. Paira, Rhupus: Report of 4 Cases, Reumatolog??a Cl??nica (English Edition), vol.7, issue.5, pp.333-338, 2011.
DOI : 10.1016/j.reumae.2010.12.003

S. Seo, S. Lee, D. Park, T. Kim, Y. Park et al., Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature, Clin Exp Rheumatol, vol.29, pp.708-719, 2011.

J. Smolen, R. Landewé, J. Bijlsma, G. Burmester, K. Chatzidionysiou et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update, Annals of the Rheumatic Diseases, vol.353, issue.(4), pp.960-77, 2017.
DOI : 10.1136/annrheumdis-2016-210715

L. Davis and A. Reimold, Research and therapeutics???traditional and emerging therapies in systemic lupus erythematosus, Rheumatology, vol.56, issue.suppl_1, pp.100-113, 2017.
DOI : 10.1093/rheumatology/kew417

L. Zhu, Y. X. Yu, and X. , Anti-TNF-alpha therapies in systemic lupus erythematosus, J Biomed Biotechnol, p.465898, 2010.

G. Illei, Y. Shirota, C. Yarboro, J. Daruwalla, E. Tackey et al., Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study, Arthritis & Rheumatism, vol.49, issue.2, pp.542-52, 2010.
DOI : 10.1002/art.27221

K. Maeshima, K. Ishii, M. Torigoe, C. Imada, M. Iwakura et al., Successful tocilizumab and tacrolimus treatment in a patient with rheumatoid arthritis complicated by systemic lupus erythematosus, Lupus, vol.21, issue.9, pp.1003-1009, 2012.
DOI : 10.1007/s00296-010-1366-9

M. Ramos-casals, M. Soto, M. Cuadrado, and M. Khamashta, Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases, Lupus, vol.17, issue.9, pp.767-76, 2009.
DOI : 10.1177/0961203308090033

L. Andrade-ortega, F. Irazoque-palazuelos, S. Muñóz-lópez, R. Pablo, and V. , Efficacy and Tolerability of Rituximab in Patients With Rhupus, Reumatolog??a Cl??nica (English Edition), vol.9, issue.4, pp.201-206, 2013.
DOI : 10.1016/j.reumae.2013.03.004

F. Araújo, I. Silva, A. Sepriano, P. Nero, and J. Branco, Off-label use of rituximab in systemic rheumatic diseases: case series and review, Acta Reumatol Port, vol.38, pp.290-294, 2013.

M. Piga, A. Gabba, A. Cauli, P. Garau, A. Vacca et al., Rituximab treatment for ???rhupus syndrome???: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study, Lupus, vol.32, issue.6, pp.624-632, 2013.
DOI : 10.1002/art.23682

H. Radner, T. Neogi, J. Smolen, and D. Aletaha, Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review, Annals of the Rheumatic Diseases, vol.69, issue.Suppl 3, pp.114-137, 2014.
DOI : 10.1136/ard.2009.122473

R. Aggarwal, S. Ringold, D. Khanna, T. Neogi, S. Johnson et al., Distinctions Between Diagnostic and Classification Criteria?, Arthritis Care & Research, vol.28, issue.7, pp.891-898, 2015.
DOI : 10.1093/rheumatology/37.10.1084

URL : http://onlinelibrary.wiley.com/doi/10.1002/acr.22583/pdf

L. De-rycke, E. Kruithof, N. Van-damme, I. Hoffman, N. Van-den-bossche et al., Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy, Arthritis & Rheumatism, vol.48, issue.4, pp.1015-1038, 2003.
DOI : 10.1002/art.10876